Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD011 Open-Label Extension in Prader-Willi Syndrome
NCT05387798Phase 3Withdrawn
- Start
- Jan 2023
- Primary completion
- Aug 2025
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of RAD011 in Prader-Willi syndrome (PWS). Planned start Jan 2023; status: withdrawn.
02
Drugs
RAD011
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT05387798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05387798.